Finally, LSC in AML and CML display various immune checkpoint antigens, including the key checkpoint target PD-L1 (CD274) and the ‘don’t eat me’ receptor IAP (CD47) (Table 1) [61,62,63]. This evidence concerns the gene CD47 and chronic myelogenous leukemia, BCR-ABL1 positive.